MedTrace Logo

Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)

NCT03000933 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-10-05

No results posted yet for this study

Summary

Australia was one of the countries to implement a universal school-based male vaccination program - in 2013. This research project will examine the prevalence of HPV among young men who have sex with men (MSM) who have been offered school-based HPV vaccination.

Conditions

  • Human Papillomavirus
  • Human Papillomavirus Infection

Sponsors & Collaborators

Eligibility

Min Age
16 Years
Max Age
20 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-16
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03000933 on ClinicalTrials.gov